title: Tenofovir resistance and first-line antiretroviral therapy.
authors.affiliation: Department of HIV, World Health Organization, Geneva, Switzerland. Electronic address: fordn@who.int.
authors.forename: Nathan
authors.initials: N
authors.lastname: Ford
authors.affiliation: Department of HIV, World Health Organization, Geneva, Switzerland.
authors.forename: Marco
authors.initials: M
authors.lastname: Vitoria
authors.affiliation: Department of HIV, World Health Organization, Geneva, Switzerland.
authors.forename: Meg
authors.initials: M
authors.lastname: Doherty
authors.affiliation: Department of HIV, World Health Organization, Geneva, Switzerland.
authors.forename: Silvia
authors.initials: S
authors.lastname: Bertagnolio
mesh_terms: D019380:Anti-HIV Agents; D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral / Q000187:drug effects; D015658:HIV Infections; D006801:Humans; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir